{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:49:41Z","timestamp":1791899381627,"version":"4.3.4"},"reference-count":70,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008836","name":"Gaziantep \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.eprac.2023.08.013","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T12:08:25Z","timestamp":1693397305000},"page":"902-911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Short Stature due to Bioinactive Growth Hormone (Kowarski Syndrome)"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2861-3568","authenticated-orcid":false,"given":"Murat","family":"Karaoglan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eprac.2023.08.013_bib1","doi-asserted-by":"crossref","first-page":"R212","DOI":"10.1530\/EC-18-0099","article-title":"The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders","volume":"7","author":"Blum","year":"2018","journal-title":"Endocr Connect"},{"issue":"1","key":"10.1016\/j.eprac.2023.08.013_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/endocrines4010001","article-title":"Idiopathic short stature: what to expect from genomic investigations","volume":"4","author":"Andrade","year":"2023","journal-title":"Endocrines"},{"key":"10.1016\/j.eprac.2023.08.013_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1096-6374(99)80079-3","article-title":"Short stature by mutant growth hormones","volume":"9 Suppl B","author":"Takahashi","year":"1999","journal-title":"Growth Horm IGF Res"},{"issue":"7","key":"10.1016\/j.eprac.2023.08.013_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM199602153340704","article-title":"Brief report: short stature caused by a mutant growth hormone [see comments]","volume":"334","author":"Takahashi","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.eprac.2023.08.013_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1210\/jcem-47-2-461","article-title":"Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH","volume":"47","author":"Kowarski","year":"1978","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2023.08.013_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF03347461","article-title":"Efficacy of long-term growth hormone therapy in short children with reduced growth hormone biological activity","volume":"34","author":"Pagani","year":"2011","journal-title":"J Endocrinol Investig"},{"issue":"3-4","key":"10.1016\/j.eprac.2023.08.013_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000516407","article-title":"Differential diagnosis of the short IGF-I-deficient child with apparently normal growth hormone secretion","volume":"94","author":"Wit","year":"2021","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"10.1016\/j.eprac.2023.08.013_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2265.2009.03775.x","article-title":"The continuum of growth hormone-IGF-I axis defects causing short stature: diagnostic and therapeutic challenges","volume":"72","author":"Savage","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.eprac.2023.08.013_bib9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/humu.10168","article-title":"Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulation of the clinical selection criteria for individuals with short stature","volume":"21","author":"Millar","year":"2003","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.eprac.2023.08.013_bib10","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1210\/jc.2004-1838","article-title":"Short stature caused by a biologically inactive mutant growth hormone (GH-C53S)","volume":"90","author":"Besson","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2023.08.013_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/eje.1.01797","article-title":"Genetic control of growth","volume":"152","author":"Mullis","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2023.08.013_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fendo.2018.00035","article-title":"The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects","volume":"9","author":"Dehkhoda","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"15","key":"10.1016\/j.eprac.2023.08.013_bib13","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1074\/jbc.RA119.009101","article-title":"Short stature explained by dimerization of human growth hormone induced by a p.C53S point mutation","volume":"295","author":"Sander","year":"2020","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.eprac.2023.08.013_bib14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1152\/physrev.1999.79.2.511","article-title":"Neuroendocrine control of growth hormone secretion","volume":"79","author":"M\u00fcller","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.eprac.2023.08.013_bib15","series-title":"The Metabolic Basis of Inherited Disease","first-page":"3023","article-title":"Inherited defects in growth hormone synthesis and action","author":"Phillips","year":"1995"},{"key":"10.1016\/j.eprac.2023.08.013_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/edrv.22.1.0419","article-title":"The somatomedin hypothesis:2001","volume":"22","author":"Le Roith","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eprac.2023.08.013_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/edrv-12-4-424","article-title":"Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins","volume":"12","author":"Baumann","year":"1991","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.eprac.2023.08.013_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ghir.2009.04.011","article-title":"Growth hormone isoforms","volume":"19","author":"Baumann","year":"2009","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.eprac.2023.08.013_bib19","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1210\/jc.2007-0526","article-title":"The somatomedin hypothesis 2007: 50 years later","volume":"92","author":"Kaplan","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2023.08.013_bib20","first-page":"825","article-title":"A\u00a0hormonally controlled serum factor which stimulates sulphate incorporation by cartilage in vitro","volume":"49","author":"Salmon","year":"1957","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.eprac.2023.08.013_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1432-0436.1985.tb00316.x","article-title":"A\u00a0dual effector theory of growth-hormone action","volume":"29","author":"Green","year":"1985","journal-title":"Differentiation"},{"issue":"2","key":"10.1016\/j.eprac.2023.08.013_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4274\/jcrpe.v2i2.52","article-title":"Genetics of isolated growth hormone deficiency","volume":"2","author":"Mullis","year":"2010","journal-title":"J\u00a0Clin Res Pediatr Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2023.08.013_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000448893","article-title":"International classification of pediatric endocrine diagnoses","volume":"86","author":"Wit","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"10.1016\/j.eprac.2023.08.013_bib24","doi-asserted-by":"crossref","first-page":"608","DOI":"10.20945\/2359-3997000000191","article-title":"Update on new GH-IGF axis genetic defects","volume":"63","author":"Vasques","year":"2019","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.eprac.2023.08.013_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fendo.2011.00095","article-title":"Genetic defects in the growth hormone-IGF-I axis causing growth hormone insensitivity and impaired linear growth","volume":"2","author":"Savage","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.eprac.2023.08.013_bib26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1210\/jc.2009-1247","article-title":"Growth hormone (GH) deficiency type II: a novel GH-1 gene mutation (GH-R178H) affecting secretion and action","volume":"95","author":"Petkovic","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2023.08.013_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3389\/fendo.2019.00602","article-title":"Genetics of growth disorders-which patients require genetic testing?","volume":"10","author":"Argente","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.eprac.2023.08.013_bib28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI119627","article-title":"Biologically inactive growth hormone caused by an amino acid substitution","volume":"100","author":"Takahashi","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.eprac.2023.08.013_bib29","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1210\/jc.2006-2238","article-title":"Evaluation of the biological activity of a growth hormone (GH) mutant (R77C) and its impact on GH responsiveness and stature","volume":"92","author":"Petkovic","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2023.08.013_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ghir.2011.04.002","article-title":"A\u00a0novel GH-1 gene mutation (GH-P59L) causes partial GH deficiency type II combined with bioinactive GH syndrome","volume":"21","author":"Petkovic","year":"2011","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"10.1016\/j.eprac.2023.08.013_bib31","doi-asserted-by":"crossref","first-page":"K35","DOI":"10.1530\/EJE-12-0847","article-title":"Short stature in two siblings heterozygous for a novel bioinactive GH mutant (GH-P59S) suggesting that the mutant also affects secretion of the wild-type GH","volume":"168","author":"Petkovic","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2023.08.013_bib32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-09-0178","article-title":"An immunologically anomalous but considerably bioactive GH produced by a novel GH1 mutation (p.D116E)","volume":"161","author":"Dateki","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2023.08.013_bib33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1248\/cpb.39.150","article-title":"Activity of artificial mutant variants of human growth hormone deficient in a disulfide bond between Cys53 and Cys165","volume":"39","author":"Uchida","year":"1991","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.eprac.2023.08.013_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ghir.2019.11.002","article-title":"p.R209H GH1 variant challenges short stature assessment","volume":"50","author":"Sanguineti","year":"2020","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"10.1016\/j.eprac.2023.08.013_bib35","first-page":"82","article-title":"Syndrome of biologically inactive growth hormone \u2014 features of diagnosis and treatment","volume":"28","author":"Sprynchuk","year":"2023","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.eprac.2023.08.013_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/endocrines3010006","article-title":"Inclusion and withdrawal criteria for growth hormone (GH) therapy in children with idiopathic GH deficiency\u2014toward following the evidence but still with unresolved problems","volume":"3","author":"Smyczy\u0144ska","year":"2022","journal-title":"Endocrines"},{"issue":"3","key":"10.1016\/j.eprac.2023.08.013_bib37","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/JOE-13-0477","article-title":"Determinants of GH resistance in malnutrition","volume":"220","author":"Fazeli","year":"2014","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.eprac.2023.08.013_bib38","first-page":"3529","article-title":"Phenotype: genotype relationships in growth hormone insensitivity syndrome","volume":"82","author":"Woods","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2023.08.013_bib39","first-page":"1","article-title":"The IGF system: new developments relevant to pediatric practice","volume":"vol 9","author":"Rosenfeld","year":"2005"},{"issue":"9","key":"10.1016\/j.eprac.2023.08.013_bib40","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00109-007-0200-7","article-title":"Combined effect of mutations of the GH1 gene and its proximal promoter region in a child with growth hormone neurosecretory dysfunction (GHND)","volume":"85","author":"Rojas-Gil","year":"2007","journal-title":"J\u00a0Mol Med (Berl)"},{"issue":"4","key":"10.1016\/j.eprac.2023.08.013_bib41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.6065\/apem.2018.23.4.176","article-title":"Growth hormone therapy in patients with Noonan syndrome","volume":"23","author":"Seo","year":"2018","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2023.08.013_bib42","first-page":"1511","article-title":"Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia","volume":"86","author":"Quintos","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3\u20134","key":"10.1016\/j.eprac.2023.08.013_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/08977194.2019.1669589","article-title":"Lowe syndrome with extremely short stature: growth hormone deficiency may be the pathogeny","volume":"37","author":"Dai","year":"2019","journal-title":"Grow Fact"},{"issue":"8","key":"10.1016\/j.eprac.2023.08.013_bib44","first-page":"MC13","article-title":"Ghrelin: Ghrelin as a regulatory peptide in growth hormone secretion","volume":"8","author":"Khatib","year":"2014","journal-title":"J\u00a0Clin Diagn Res"},{"key":"10.1016\/j.eprac.2023.08.013_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40842-018-0068-1","article-title":"Growth hormone: isoforms, clinical aspects and assays interference","volume":"4","author":"Ribeiro de Oliveira Longo Schweizer","year":"2018","journal-title":"Clin Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2023.08.013_bib46","first-page":"1439","article-title":"Circulating growth hormone isoforms in girls with Turner's syndrome","volume":"78","author":"Blethen","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2023.08.013_bib47","first-page":"2944","article-title":"Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure","volume":"82","author":"Boguszewski","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2023.08.013_bib48","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1210\/jc.2005-0132","article-title":"Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly","volume":"90","author":"Filopanti","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2023.08.013_bib49","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1055-9965.EPI-08-0893","article-title":"Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk","volume":"18","author":"Johansson","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.eprac.2023.08.013_bib50","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1210\/jc.2015-3880","article-title":"IGSF1 deficiency: lessons from an extensive case series and recommendations for clinical management","volume":"101","author":"Joustra","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2023.08.013_bib51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrendo.2016.138","article-title":"Diagnosis and management of Silver-Russell syndrome: first international consensus statement","volume":"13","author":"Wakeling","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2023.08.013_bib52","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jpeds.2003.09.052","article-title":"IMAGe syndrome: a complex disorder affecting growth, adrenal and gonadal function, and skeletal development","volume":"144","author":"Pedreira","year":"2004","journal-title":"J\u00a0Pediatr"},{"issue":"8","key":"10.1016\/j.eprac.2023.08.013_bib53","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ejhg.2012.262","article-title":"Frequency and characterization of DNA methylation defects in children born SGA","volume":"21","author":"Bens","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.eprac.2023.08.013_bib54","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ajhg.2019.02.023","article-title":"De novo and inherited pathogenic variants in KDM3B cause intellectual disability, short stature, and facial dysmorphism","volume":"104","author":"Diets","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"Suppl 2","key":"10.1016\/j.eprac.2023.08.013_bib55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12920-019-0487-6","article-title":"The role of long noncoding RNAs in the pathogenesis of hereditary diseases","volume":"12","author":"Sparber","year":"2019","journal-title":"BMC Med Genomics"},{"issue":"1","key":"10.1016\/j.eprac.2023.08.013_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000504669","article-title":"The role of MicroRNAs in influencing body growth and development","volume":"93","author":"Cirillo","year":"2020","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"10.1016\/j.eprac.2023.08.013_bib57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.6065\/apem.2040018.009","article-title":"Discriminatory performance of insulin-like growth factor 1 and insulin-like growth factor binding protein-3 by correlating values to chronological age, bone age, and pubertal status for diagnosis of isolated growth hormone deficiency","volume":"25","author":"Choi","year":"2020","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.eprac.2023.08.013_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.902364","article-title":"Growth hormone stimulation testing: to test or not to test? That is one of the questions","volume":"13","author":"Yau","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.eprac.2023.08.013_bib59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/EJE-11-0618","article-title":"Diagnosis of endocrine disease: limitations of the IGF1 generation test in children with short stature","volume":"166","author":"Coutant","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2023.08.013_bib60","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2265.2006.02718.x","article-title":"Human growth hormone (GH1) gene polymorphism map in a normal-statured adult population","volume":"66","author":"Esteban","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2023.08.013_bib61","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1210\/jcem.86.11.8019","article-title":"The IGF-I generation test revisited: a marker of GH sensitivity","volume":"86","author":"Buckway","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2023.08.013_bib62","first-page":"40","article-title":"Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children","volume":"21","author":"Ali","year":"2009","journal-title":"J\u00a0Ayub Med Coll Abbottabad"},{"issue":"6","key":"10.1016\/j.eprac.2023.08.013_bib63","doi-asserted-by":"crossref","first-page":"618","DOI":"10.20945\/2359-3997000000192","article-title":"Laboratory investigations in the diagnosis and follow-up of GH-related disorders","volume":"63","author":"Schilbach","year":"2019","journal-title":"Arch Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2023.08.013_bib64","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency","volume":"86","author":"Grimberg","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"10.1016\/j.eprac.2023.08.013_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000502231","article-title":"Diagnosis, genetics, and therapy of short stature in children: a Growth Hormone Research Society international perspective","volume":"92","author":"Collett-Solberg","year":"2019","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"10.1016\/j.eprac.2023.08.013_bib66","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4274\/jcrpe.galenos.2019.2019.0176","article-title":"A\u00a0proposal for the interpretation of serum IGF-I concentration as part of laboratory screening in children with growth failure","volume":"12","author":"Wit","year":"2020","journal-title":"J\u00a0Clin Res Pediatr Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2023.08.013_bib67","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1530\/EC-20-0347","article-title":"IGF1 for the diagnosis of growth hormone deficiency in children and adolescents: a reappraisal","volume":"9","author":"Ibba","year":"2020","journal-title":"Endocr Connect"},{"key":"10.1016\/j.eprac.2023.08.013_bib68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000085757","article-title":"IGF-I and IGFBP-3 assessment in the management of childhood onset growth hormone deficiency","volume":"9","author":"Cianfarani","year":"2005","journal-title":"Endocr Dev"},{"issue":"7","key":"10.1016\/j.eprac.2023.08.013_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252283","article-title":"Factors affecting IGF-I level and correlation with growth response during growth hormone treatment in LG growth study","volume":"16","author":"Kim","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.eprac.2023.08.013_bib70","first-page":"287","article-title":"Clinical significance and molecular mechanisms of bioinactive growth hormone (review)","volume":"2","author":"Takahashi","year":"1998","journal-title":"Int J Mol Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23005384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23005384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:15:41Z","timestamp":1761516941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X23005384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1530891X23005384"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2023.08.013","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short Stature due to Bioinactive Growth Hormone (Kowarski Syndrome)","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2023.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}